ClinConnect ClinConnect Logo
Search / Trial NCT06438549

Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation

Launched by LOMA LINDA UNIVERSITY · May 30, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Prevention Treatment Disparities And Social Inequality Tobacco Use Cessation Community Health Worker Pregnant Smokers

ClinConnect Summary

This clinical trial is looking at a new program designed to help pregnant women in San Bernardino County quit smoking. The study is focused on integrating Community Health Workers (CHWs) into prenatal care to support expectant mothers who smoke. If you are a woman who is currently pregnant (less than 24 weeks along), over 18 years old, and smoke more than three cigarettes a day, you may be eligible to join this program. Participants need to be willing to set a quit date within two weeks of enrolling and must be receiving prenatal care at specific health centers.

If you choose to participate, you can expect to receive support from trained health workers who will guide you through the quitting process. They will help you develop a personalized plan to stop smoking and offer encouragement along the way. It's important to note that this trial is currently recruiting participants, so there is an opportunity for you to be part of this valuable research that aims to improve the health of mothers and their babies by reducing smoking during pregnancy.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • \< 24 weeks pregnant
  • age \> 18 years,
  • current smokers (100 cigarettes in their lifetime and \>3 cigarettes per day in the last 7 days; including poly-tobacco use, combining cigarettes with non-combustible products) confirmed by expired carbon monoxide (CO)
  • willing to quit smoking and set a quit date in the next 2 weeks upon enrolling
  • enrolled in prenatal care at Loma Linda University Health (LLUH) or Riverside University Health System (RUHS)
  • Exclusion Criteria:
  • severe mental health problems that prevent informed consent and/or CHW intervention
  • women who were on Nicotine Replacement Therapy (NRT) or enrolled in a cessation program within 30 days
  • unwillingness to participate in audio-recorded key informant interviews or focus groups

About Loma Linda University

Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.

Locations

Loma Linda, California, United States

Moreno Valley, California, United States

Patients applied

0 patients applied

Trial Officials

Anne Berit Petersen, PhD

Principal Investigator

Loma Linda University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported